This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Khanh Bui: Innovator in Pharmaceutical Chemistry
Introduction
Khanh Bui is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical chemistry. His work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
Khanh Bui holds a patent for a compound titled N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide. This patent includes pharmaceutically acceptable salts and mixtures thereof, as well as pharmaceutical compositions, methods of treatment, and processes for making the compound and its intermediates. He has 1 patent to his name.
Career Highlights
Khanh Bui is currently employed at AstraZeneca, a leading global biopharmaceutical company. His role involves research and development of new pharmaceutical products. His expertise in medicinal chemistry has been instrumental in advancing the company's innovative drug pipeline.
Collaborations
Khanh has collaborated with several talented individuals in his field, including Megan Murphy King and Cathy Dantzman. These collaborations have fostered a productive environment for innovation and discovery.
Conclusion
Khanh Bui is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry positively. His innovative approaches and collaborations highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile